ProMeris

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris has been withdrawn at the request of the marketing authorisation holder.

български (BG) (217.29 KB - PDF)

Zobacz

español (ES) (192.56 KB - PDF)

Zobacz

čeština (CS) (217.67 KB - PDF)

Zobacz

dansk (DA) (191.94 KB - PDF)

Zobacz

Deutsch (DE) (193.36 KB - PDF)

Zobacz

eesti (ET) (191.37 KB - PDF)

Zobacz

ελληνικά (EL) (219.08 KB - PDF)

Zobacz

français (FR) (193.21 KB - PDF)

Zobacz

italiano (IT) (191.59 KB - PDF)

Zobacz

latviešu (LV) (213.28 KB - PDF)

Zobacz

lietuvių (LT) (214.74 KB - PDF)

Zobacz

magyar (HU) (212.15 KB - PDF)

Zobacz

Malti (MT) (218.75 KB - PDF)

Zobacz

Nederlands (NL) (191.68 KB - PDF)

Zobacz

polski (PL) (216.46 KB - PDF)

Zobacz

português (PT) (192.4 KB - PDF)

Zobacz

română (RO) (214.2 KB - PDF)

Zobacz

slovenčina (SK) (215.86 KB - PDF)

Zobacz

slovenščina (SL) (208.53 KB - PDF)

Zobacz

suomi (FI) (191.92 KB - PDF)

Zobacz

svenska (SV) (191.72 KB - PDF)

Zobacz

Product information

български (BG) (389.52 KB - PDF)

Zobacz

español (ES) (328.73 KB - PDF)

Zobacz

čeština (CS) (374.1 KB - PDF)

Zobacz

dansk (DA) (330.12 KB - PDF)

Zobacz

Deutsch (DE) (340.98 KB - PDF)

Zobacz

eesti (ET) (336.16 KB - PDF)

Zobacz

ελληνικά (EL) (400.6 KB - PDF)

Zobacz

français (FR) (342.69 KB - PDF)

Zobacz

italiano (IT) (310.69 KB - PDF)

Zobacz

latviešu (LV) (368.86 KB - PDF)

Zobacz

lietuvių (LT) (376.46 KB - PDF)

Zobacz

magyar (HU) (368.57 KB - PDF)

Zobacz

Malti (MT) (376.05 KB - PDF)

Zobacz

Nederlands (NL) (331.24 KB - PDF)

Zobacz

polski (PL) (391.6 KB - PDF)

Zobacz

português (PT) (331.45 KB - PDF)

Zobacz

română (RO) (368.38 KB - PDF)

Zobacz

slovenčina (SK) (386.11 KB - PDF)

Zobacz

slovenščina (SL) (371.43 KB - PDF)

Zobacz

suomi (FI) (337.57 KB - PDF)

Zobacz

svenska (SV) (330.13 KB - PDF)

Zobacz

Íslenska (IS) (332.3 KB - PDF)

Zobacz

norsk (NO) (340.4 KB - PDF)

Zobacz
Latest procedure affecting product information:IB/0012
08/07/2015

български (BG) (190.37 KB - PDF)

Zobacz

español (ES) (144.19 KB - PDF)

Zobacz

čeština (CS) (184.81 KB - PDF)

Zobacz

dansk (DA) (144.38 KB - PDF)

Zobacz

Deutsch (DE) (146.91 KB - PDF)

Zobacz

eesti (ET) (144.06 KB - PDF)

Zobacz

ελληνικά (EL) (186.84 KB - PDF)

Zobacz

français (FR) (141.5 KB - PDF)

Zobacz

italiano (IT) (144.6 KB - PDF)

Zobacz

latviešu (LV) (189.21 KB - PDF)

Zobacz

lietuvių (LT) (179.82 KB - PDF)

Zobacz

magyar (HU) (175.56 KB - PDF)

Zobacz

Malti (MT) (198.96 KB - PDF)

Zobacz

Nederlands (NL) (141.54 KB - PDF)

Zobacz

polski (PL) (163.63 KB - PDF)

Zobacz

português (PT) (144.35 KB - PDF)

Zobacz

română (RO) (142.48 KB - PDF)

Zobacz

slovenčina (SK) (181.1 KB - PDF)

Zobacz

slovenščina (SL) (174.66 KB - PDF)

Zobacz

suomi (FI) (144.95 KB - PDF)

Zobacz

svenska (SV) (141.76 KB - PDF)

Zobacz

Íslenska (IS) (141.82 KB - PDF)

Zobacz

norsk (NO) (141.71 KB - PDF)

Zobacz

Product details

Name of medicine
ProMeris
Active substance
metaflumizone
International non-proprietary name (INN) or common name
metaflumizone
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AX25

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000107
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
8

Assessment history

This page was last updated on

Share this page